Stanley Laman Group, Ltd. Bristol Myers Squibb CO Transaction History
Stanley Laman Group, Ltd.
- $636 Million
- Q2 2024
A detailed history of Stanley Laman Group, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 9,010 shares of BMY stock, worth $479,512. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,010
Previous 6,340
42.11%
Holding current value
$479,512
Previous $343,000
9.04%
% of portfolio
0.06%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,425Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.93 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.87 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...